ES2118818T3 - Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo. - Google Patents

Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo.

Info

Publication number
ES2118818T3
ES2118818T3 ES92910172T ES92910172T ES2118818T3 ES 2118818 T3 ES2118818 T3 ES 2118818T3 ES 92910172 T ES92910172 T ES 92910172T ES 92910172 T ES92910172 T ES 92910172T ES 2118818 T3 ES2118818 T3 ES 2118818T3
Authority
ES
Spain
Prior art keywords
obtaining
tiazolin
aminoalquil
onas
employment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910172T
Other languages
English (en)
Inventor
Beatrice Rendenbach-Mueller
Hans-Juergen Teschendorf
Liliane Unger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Application granted granted Critical
Publication of ES2118818T3 publication Critical patent/ES2118818T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

SE DESCRIBEN DERIVADOS TIAZOLINA OR AMINOALQUILO DE LA FORMULA (I) EN DONDE N Y A TIENEN EL SIGNIFICADO DEFINIDO EN LA DESCRIPCION, ASI COMO SU OBTENCION. LOS COMPUESTOS SON ADECUADOS PARA EL TRATAMIENTO DE ENFERMEDADES.
ES92910172T 1991-06-15 1992-05-12 Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo. Expired - Lifetime ES2118818T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4119757A DE4119757A1 (de) 1991-06-15 1991-06-15 Aminoalkylsubstituierte thiazolin-2-one, ihre herstellung und verwendung

Publications (1)

Publication Number Publication Date
ES2118818T3 true ES2118818T3 (es) 1998-10-01

Family

ID=6434011

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910172T Expired - Lifetime ES2118818T3 (es) 1991-06-15 1992-05-12 Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo.

Country Status (9)

Country Link
US (1) US5401762A (es)
EP (1) EP0589908B1 (es)
JP (1) JPH06508113A (es)
AT (1) ATE169012T1 (es)
CA (1) CA2111441A1 (es)
DE (2) DE4119757A1 (es)
DK (1) DK0589908T3 (es)
ES (1) ES2118818T3 (es)
WO (1) WO1992022539A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801186A (en) * 1987-11-20 1998-09-01 Hoechst Marion Roussel, Inc. 3- 4-(1-substituted-4-piperazinyl)butyl!-4-thiazolidinone and related compounds
DE4425145A1 (de) * 1994-07-15 1996-01-18 Basf Ag Verwendung von Thiazol- und Thiadiazolverbindungen
AU718519B2 (en) * 1996-09-20 2000-04-13 Nihon Nohyaku Co., Ltd. 2-carbonylthiazole derivative and use thereof
US6423708B1 (en) 1996-09-30 2002-07-23 Pfizer Inc Aralkyl and aralkylidene heterocyclic lactams and imides
UA56185C2 (uk) 1996-09-30 2003-05-15 Пфайзер Інк. Аралкіл- та аралкіліденгетероциклічні лактами та іміди, фармацевтична композиція та спосіб лікування
DE19728996A1 (de) 1997-07-07 1999-01-14 Basf Ag Triazolverbindungen und deren Verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones

Also Published As

Publication number Publication date
DE4119757A1 (de) 1992-12-17
DE59209437D1 (de) 1998-09-03
EP0589908B1 (de) 1998-07-29
JPH06508113A (ja) 1994-09-14
US5401762A (en) 1995-03-28
CA2111441A1 (en) 1992-12-23
DK0589908T3 (da) 1998-10-26
ATE169012T1 (de) 1998-08-15
EP0589908A1 (de) 1994-04-06
WO1992022539A1 (de) 1992-12-23

Similar Documents

Publication Publication Date Title
ES2167377T3 (es) Derivados de piridina farmacologicamente activos y procedimientos para la preparacion de los mismos.
ES2150989T3 (es) Nuevos derivados de quinoxalinadiona, su preparacion y empleo en medicamentos.
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ES2161697T3 (es) Peptidos agonistas de amilina y usos de los mismos.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
ES2160602T3 (es) Derivados de quinolona y acridinona para el tratamiento de la incontinencia urinaria.
MX9606300A (es) Arilalquiltioalquiltiopiridinas substituidas para combatir bacterias helicobactas.
ES2116496T3 (es) Proceso para la preparacion de 1,4-disubstituido-5(4h)-tetrazolinonas.
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
ES2144154T3 (es) Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
ES2094344T3 (es) Compuestos anti-virales.
ES2064119T3 (es) Nuevos derivados de aminobenzosultam como inhibidores de la lipoxigenasa.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ES2177811T3 (es) Uso de nitroflavonoides para el tratamiento de la ansiedad.
ES2154311T3 (es) Quinoxalinas, procedimiento para su preparacion y su utilizacion.
ES2118818T3 (es) Tiazolin-2-onas aminoalquil-substituidas, su obtencion y empleo.
ES2166830T3 (es) Derivados 2,7-sustituidos de octahidro-1h-pirido(1,2-a)pirazina.
ES2061811T3 (es) Uso de compuestos de gamma-oxibutenolido conjugados para tratar ulcera.
ES2032317T3 (es) Derivados de quinazolina tetraciclicos, obtencion y empleo.
ES2074508T3 (es) Benzocicloalquilaminopiridinaminas y compuestos afines, un procedimiento e intermediarios para su preparacion y su uso como medicamentos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 589908

Country of ref document: ES